ZA201403617B - Mutated lentiviral env proteins and their use as drugs - Google Patents

Mutated lentiviral env proteins and their use as drugs

Info

Publication number
ZA201403617B
ZA201403617B ZA2014/03617A ZA201403617A ZA201403617B ZA 201403617 B ZA201403617 B ZA 201403617B ZA 2014/03617 A ZA2014/03617 A ZA 2014/03617A ZA 201403617 A ZA201403617 A ZA 201403617A ZA 201403617 B ZA201403617 B ZA 201403617B
Authority
ZA
South Africa
Prior art keywords
drugs
env proteins
lentiviral env
mutated lentiviral
mutated
Prior art date
Application number
ZA2014/03617A
Other languages
English (en)
Inventor
Heidmann Thierry
Original Assignee
Centre Nat Rech Scient
Roussy Inst Gustave
Viroxis S A S
Univ Paris-Sud Xi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Roussy Inst Gustave, Viroxis S A S, Univ Paris-Sud Xi filed Critical Centre Nat Rech Scient
Publication of ZA201403617B publication Critical patent/ZA201403617B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA2014/03617A 2011-12-07 2014-05-19 Mutated lentiviral env proteins and their use as drugs ZA201403617B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11306625 2011-12-07
PCT/EP2012/074835 WO2013083799A1 (en) 2011-12-07 2012-12-07 Mutated lentiviral env proteins and their use as drugs

Publications (1)

Publication Number Publication Date
ZA201403617B true ZA201403617B (en) 2015-07-29

Family

ID=47435901

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/03617A ZA201403617B (en) 2011-12-07 2014-05-19 Mutated lentiviral env proteins and their use as drugs

Country Status (16)

Country Link
US (1) US9682137B2 (enExample)
EP (1) EP2788372B1 (enExample)
JP (2) JP6415324B2 (enExample)
KR (1) KR102059918B1 (enExample)
CN (1) CN104169295B (enExample)
AU (1) AU2012350258B2 (enExample)
BR (1) BR112014013704B1 (enExample)
CA (1) CA2856180C (enExample)
DK (1) DK2788372T3 (enExample)
ES (1) ES2748864T3 (enExample)
IL (1) IL232926B (enExample)
IN (1) IN2014CN04927A (enExample)
MX (1) MX350689B (enExample)
RU (1) RU2654673C2 (enExample)
WO (1) WO2013083799A1 (enExample)
ZA (1) ZA201403617B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11351247B2 (en) * 2017-09-01 2022-06-07 Inprother Aps Vaccine for use in the prophylaxis and/or treatment of a disease
CN117500931A (zh) * 2021-01-13 2024-02-02 维洛克塞斯 麻疹-hiv或麻疹-htlv疫苗
US20240093233A1 (en) 2021-01-13 2024-03-21 Viroxis Measles-hiv or measles-htlv vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1201750A1 (en) * 2000-10-26 2002-05-02 Genopoietic Synthetic viruses and uses thereof
WO2005012502A2 (en) 2003-03-28 2005-02-10 Idm Pharma, Inc. Methods of identifying optimal variants of peptide epitopes
AU2005229411B2 (en) * 2004-03-30 2010-11-18 Centre National De La Recherche Scientifique Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins
EP2420248A1 (en) 2004-08-17 2012-02-22 Institut Gustave Roussy Mutated HIV NEF for modulating immunity
CA2735278A1 (en) 2008-08-28 2010-03-04 Aarhus Universitet Hiv-1 envelope polypeptides for hiv vaccine
RU2426788C1 (ru) * 2010-03-01 2011-08-20 Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФГУН ЦНИИЭ Роспотребнадзора) Генетические конструкции для антивич-терапии

Also Published As

Publication number Publication date
DK2788372T3 (da) 2019-10-14
RU2654673C2 (ru) 2018-05-21
JP2018150370A (ja) 2018-09-27
AU2012350258B2 (en) 2017-03-02
ES2748864T3 (es) 2020-03-18
RU2014127521A (ru) 2016-02-10
IN2014CN04927A (enExample) 2015-09-18
EP2788372A1 (en) 2014-10-15
EP2788372B1 (en) 2019-07-10
AU2012350258A8 (en) 2014-07-17
US9682137B2 (en) 2017-06-20
IL232926A0 (en) 2014-07-31
CN104169295B (zh) 2020-07-28
BR112014013704B1 (pt) 2023-01-31
CA2856180C (en) 2022-09-06
MX2014006744A (es) 2014-12-08
JP2015505836A (ja) 2015-02-26
KR102059918B1 (ko) 2020-02-11
MX350689B (es) 2017-09-13
BR112014013704A2 (pt) 2021-02-17
AU2012350258A1 (en) 2014-06-05
CN104169295A (zh) 2014-11-26
WO2013083799A1 (en) 2013-06-13
IL232926B (en) 2019-01-31
CA2856180A1 (en) 2013-06-13
US20140294880A1 (en) 2014-10-02
JP6415324B2 (ja) 2018-10-31
KR20140116091A (ko) 2014-10-01

Similar Documents

Publication Publication Date Title
HUE055505T2 (hu) Anti-CGRP készítmények és alkalmazásuk
ZA201403264B (en) Neutralizing gp41 antibodies and their use
SG184289A1 (en) Novel peptides and methods for their preparation and use
ZA201400562B (en) Axmi205 variant proteins and methods for their use
BR112013022869A2 (pt) cápsula de entrega de bebida e métodos para uso e produção
GB201807346D0 (en) Modified base detection with nanopore sequencing
HUE054444T2 (hu) Prolinnal lezárt kapcsos peptidek és felhasználásuk
HUE039175T2 (hu) Ragasztóanyag és az annak alkalmazásával elõállított termék
IL229963A0 (en) Substituted quinolines and their use as medicaments
ZA201402910B (en) Immunogenic complexes of polyanionic carbomers and env polypeptides and methods of manufacture and use thereof
ZA201309165B (en) Mixer sensors and methods for using same
ZA201407276B (en) Polypeptides and their use
IL231666B (en) Use of non-subtype b gag proteins for lentiviral packaging
EP2762149A4 (en) PEPTIDE DERIVED FROM ERYTHROPOIETIN AND USE THEREOF
IL229956B (en) Mphosphi peptides and vaccines including the same
WO2013190509A3 (en) Preparation of intermediates of boceprevir
IL232926A0 (en) Mutated lentiviral env proteins and their use as drugs
GB201212550D0 (en) B cell assay
IL232809A0 (en) Carboxamides converted at position 2 in isothiazolopyridine and their use as medicinal preparations
PL2895176T3 (pl) Związek pośredni Rywaroksabanu i jego wytwarzanie
GB201112578D0 (en) Pharmaceutical preparation and use
GB201112000D0 (en) Biological materials and uses thereof
GB201115285D0 (en) Biosensor and uses thereof
HK1191950A (en) Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
GB201114341D0 (en) Reagent and use